{"id":122912,"date":"2014-08-21T09:40:38","date_gmt":"2014-08-21T13:40:38","guid":{"rendered":"https:\/\/www.kff.org\/?post_type=news-summary&p=122912"},"modified":"2014-08-21T09:40:38","modified_gmt":"2014-08-21T13:40:38","slug":"experts-discuss-use-of-new-tb-drug-bedaquiline","status":"publish","type":"news-summary","link":"https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/","title":{"rendered":"Experts Discuss Use Of New TB Drug Bedaquiline"},"content":{"rendered":"<p>Global Health Technologies Coalition’s “<a href=\"http:\/\/blog.ghtcoalition.org\/2014\/08\/20\/new-tb-drug-bedaquiline-weighing-the-benefits-against-the-risks\/\">Breakthroughs<\/a>”: New TB drug bedaquiline: Weighing the benefits against the risks<br \/>\nThe blog interviews Laia Ruiz Mingote and Dorothy Namutamba, co-chairs of the Community Research Advisors Group (CRAG), and Mike Watson Frick, the TB\/HIV program officer at the Treatment Action Group, about the benefits and risks of using the new drug bedaquiline to treat TB (Chmiola, 8\/20).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Global Health Technologies Coalition’s “Breakthroughs”: New TB drug bedaquiline: Weighing the benefits against the risks The blog interviews Laia Ruiz Mingote and Dorothy Namutamba, co-chairs of the Community Research Advisors Group (CRAG), and Mike Watson Frick, the TB\/HIV program officer at the Treatment Action Group, about the benefits and risks of using the new drug<span class=\"readmore-ellipsis\">…<\/span><a href=\"https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/\" class=\"see-more light-beige no-float inline-readmore\">More<\/a><\/p>\n","protected":false},"author":48988639,"featured_media":0,"menu_order":0,"template":"","class_list":["post-122912","news-summary","type-news-summary","status-publish","hentry","daily-news-tags-tuberculosis","daily-news-tags-treatment-and-prevention-strategies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Experts Discuss Use Of New TB Drug Bedaquiline | KFF<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Experts Discuss Use Of New TB Drug Bedaquiline | KFF\" \/>\n<meta property=\"og:description\" content=\"Global Health Technologies Coalition’s “Breakthroughs”: New TB drug bedaquiline: Weighing the benefits against the risks The blog interviews Laia Ruiz Mingote and Dorothy Namutamba, co-chairs of the Community Research Advisors Group (CRAG), and Mike Watson Frick, the TB\/HIV program officer at the Treatment Action Group, about the benefits and risks of using the new drug…More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/\" \/>\n<meta property=\"og:site_name\" content=\"KFF\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/\",\"url\":\"https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/\",\"name\":\"Experts Discuss Use Of New TB Drug Bedaquiline | KFF\",\"isPartOf\":{\"@id\":\"https:\/\/www.kff.org\/#website\"},\"datePublished\":\"2014-08-21T13:40:38+00:00\",\"dateModified\":\"2014-08-21T13:40:38+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.kff.org\/#website\",\"url\":\"https:\/\/www.kff.org\/\",\"name\":\"KFF\",\"description\":\"The independent source for health policy research, polling, and news\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.kff.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Experts Discuss Use Of New TB Drug Bedaquiline | KFF","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/","og_locale":"en_US","og_type":"article","og_title":"Experts Discuss Use Of New TB Drug Bedaquiline | KFF","og_description":"Global Health Technologies Coalition’s “Breakthroughs”: New TB drug bedaquiline: Weighing the benefits against the risks The blog interviews Laia Ruiz Mingote and Dorothy Namutamba, co-chairs of the Community Research Advisors Group (CRAG), and Mike Watson Frick, the TB\/HIV program officer at the Treatment Action Group, about the benefits and risks of using the new drug…More","og_url":"https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/","og_site_name":"KFF","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/","url":"https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/","name":"Experts Discuss Use Of New TB Drug Bedaquiline | KFF","isPartOf":{"@id":"https:\/\/www.kff.org\/#website"},"datePublished":"2014-08-21T13:40:38+00:00","dateModified":"2014-08-21T13:40:38+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kff.org\/news-summary\/experts-discuss-use-of-new-tb-drug-bedaquiline\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.kff.org\/#website","url":"https:\/\/www.kff.org\/","name":"KFF","description":"The independent source for health policy research, polling, and news","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kff.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/news-summary\/122912"}],"collection":[{"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/news-summary"}],"about":[{"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/types\/news-summary"}],"author":[{"embeddable":true,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/users\/48988639"}],"version-history":[{"count":1,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/news-summary\/122912\/revisions"}],"predecessor-version":[{"id":122914,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/news-summary\/122912\/revisions\/122914"}],"wp:attachment":[{"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/media?parent=122912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}